Publication at Third Faculty of Medicine |
2006
Abstract
Erectile dysfunction (ED) is, with an incidence rate of 10%, the most common sexual dysfunction in male adult populations. The intracavernous application of vasoactive agents has been used in treating ED for more than 20 years.
This method is based on "selfinjecting" vasoactive agents into the corpora carvernosa. The dosage is strictly individual and alprostadil is the most frequently used drug.
This treatment gives two great advantages - high efficacy and erection without sexual stimulation, and disadvantages - discomfort associated with therapy and above all the risk of prolonged erection. This treatment is safe and adheres to the rules; however, it is necessary to follow up the patient with an urologist.